Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
AXSM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
GWPHGW Pharmaceuticals PLC Sponsored ADR
1.75%187.216.2%$90.72m
AMRNAmarin Corporation Plc Sponsored ADR
1.62%17.601.8%$89.22m
SAGESAGE Therapeutics, Inc.
2.88%175.958.7%$78.55m
PRGOPerrigo Co. Plc
-0.42%49.586.8%$70.55m
ICPTIntercept Pharmaceuticals, Inc.
-1.69%86.2718.6%$65.54m
JAZZJazz Pharmaceuticals Plc
0.72%140.922.3%$64.02m
UTHRUnited Therapeutics Corporation
-1.92%87.0514.3%$58.53m
ZYNEZynerba Pharmaceuticals Inc
-1.08%14.668.3%$45.27m
ICLRICON Plc
0.96%139.354.1%$41.15m
MDCOMedicines Company
-1.28%33.2521.8%$36.68m
CTLTCatalent Inc
0.44%46.212.4%$36.62m
MNKMallinckrodt Plc
-6.48%9.2321.0%$34.96m
HZNPHorizon Pharma plc
-1.46%25.576.7%$34.65m
AXSMAxsome Therapeutics, Inc.
6.31%25.092.1%$34.41m
PCRXPacira Pharmaceuticals, Inc.
-0.96%43.4610.5%$34.28m

Company Profile

Axsome Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel therapies for the management of central nervous system disorders. Its product candidates include AXS-02 and AXS-06 which are developing for multiple indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.